Salofalk 1000 mg gastro-resistant prolonged-release granules 100 shashets (mesalazime)

What Salofalk 1000 mg granules are and what they are used for
Salofalk granules contain the active substance mesalazine, an anti-inflammatory agent used to treat inflammatory bowel disease.

Salofalk 1000 mg granules are used for:
the treatment of acute conditions and the prevention of future episodes (recurrence) of an inflammatory disease limited to the colon (colon) known to physicians as ulcerative colitis.
The active substance is mesalazine and a sachet of Salofalk 1000 mg granules contains 1000 mg mesalazine.
The other ingredients are: aspartame (E 951); carmellose sodium; cellulose, microcrystalline, citric acid, anhydrous; silica, colloidal anhydrous; hypromellose, magnesium stearate; methacrylic acid-methyl methacrylate copolymer (1: 1) (Eudragit L 100) methylcellulose; polyacrylate dispersion, 40% (Eudragit NE 40 D containing nonoxynol 100); povidone K 25; simethicone; sorbic acid; talc; titanium dioxide (E 171); triethyl citrate; vanilla cream caramel (containing sucrose)
What Salofalk 1000 mg granules look like and contents of the pack
Salofalk 1000 mg prolonged-release gastro-resistant granules are rod-shaped or round, gray-white granules.
Each sachet contains 1.86 g of granules.
Salofalk 1000 mg granules are supplied in packs of 20, 50,60,100 and 150 sachets.
Not all pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer
Dr. Falk Pharma GmbH Leinenweberstr. 5 79108 Freiburg Germany